BioMarin Pharmaceutical Inc. ( BMRN) - Stock Earnings
BMRN Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Oct. 26, 2026, midnight | — / — | — | — / — | — |
BMRN Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -46.6 million USD | 874.6 million USD |
| 2026Q1 | 105.5 million USD | 766.2 million USD |
| 2026Q2 | 44.8 million USD | 989.7 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
BMRN Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 167.6 million USD | 2.4 billion USD |
| 2024 | 426.9 million USD | 2.9 billion USD |
| 2025 | 348.9 million USD | 3.2 billion USD |
| 2026 Est. | — | — |
BMRN
Price: $55.30
Earnings Per Share: 0.37 USD
P/E Ratio: 189.84
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.1 million
Ebitda: 11.0 millionMarket Capitalization: 11.1 billion